Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Deloitte
McKesson
Covington
US Army
Farmers Insurance
UBS
Queensland Health
Healthtrust

Generated: January 19, 2018

DrugPatentWatch Database Preview

DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Dialyte Concentrate W/ Dextrose 50% In Plastic Container patents expire, and when can generic versions of Dialyte Concentrate W/ Dextrose 50% In Plastic Container launch?

Dialyte Concentrate W/ Dextrose 50% In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER is calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride. There are two hundred and seventy-two drug master file entries for this compound. Additional details are available on the calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride profile page.
Summary for DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER
Drug patent expirations by year for DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER

US Patents and Regulatory Information for DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride SOLUTION;INTRAPERITONEAL 018807-002 Aug 26, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun DIALYTE CONCENTRATE W/ DEXTROSE 50% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium acetate; sodium chloride SOLUTION;INTRAPERITONEAL 018807-004 Aug 26, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
US Department of Justice
Moodys
Healthtrust
AstraZeneca
Cantor Fitzgerald
Fuji
Cerilliant
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot